AzTrials
AzTrials

Perioperative/Postoperative ComplicationsArCanUSNCT05249036

Arterial Cannulation With Ultrasound

A study testing Ultrasound guided arterial cannulation and Palpation guided arterial cannulation in people with Perioperative/Postoperative Complications, run by Queen Mary University of London at 1 site in United Kingdom.

Terminated

Stopped early. The study ended before it was planned to and will not resume.

Official record
Search all trials

Trial summary

A drop in blood pressure during anaesthesia for a surgical procedure has been associated with worse patient outcomes, including complications such as damage to the heart, brain and kidneys. Read more about this study

Who is it for?
Ages 45 years and olderHealthy volunteers can take part
What is being tested?
Ultrasound guided arterial cannulation and Palpation guided arterial cannulation
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
57 participants
Where
1 siteUnited Kingdom
Study dates
25 Dec 2021to 30 Nov 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 45 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Patients scheduled to undergo major elective or urgent (not requiring intervention in <24 hours) non-cardiac surgery under general anaesthesia and/or neuraxial anaesthesia, expected to take >120 minutes from induction of anaesthesia
  • Requiring overnight hospital stay.

Who cannot join

  • Anatomical deformity
  • Unable to consent
  • Cannulation attempt within 24 hours
  • Overlying infection

Trial locations and contacts

1 site in 1 country.

United Kingdom1 site
  • Royal London Hospital

    London, E1

Other trials in United Kingdom

About this study

A drop in blood pressure during anaesthesia for a surgical procedure has been associated with worse patient outcomes, including complications such as damage to the heart, brain and kidneys. Continuous blood pressure monitoring prior to the start of anaesthesia alerts the anaesthetist to drops in blood pressure and allows this to be treated promptly. This may help to avoid the complications described above.

Continuous blood pressure monitoring is carried out by inserting a small plastic tube (cannula) into an artery. In this study, the investigators propose inserting a cannula into the radial artery in the wrist before a patient is anaesthetised for surgery. The usual technique for insertion of this cannula is for the anaesthetist to identify the site of the radial artery by feeling for an arterial pulse with the fingertips (palpation). An alternative technique for identification is to use ultrasound. Ultrasound creates a two-dimensional image of the area under the skin on a screen, enabling the operator to visualise the artery being targeted. This may reduce the number of cannulation attempts required, reducing patient discomfort.

Read the detailed description

The investigators will test whether ultrasound guidance improves the success rate of radial artery cannulation, compared to palpation alone, in a randomised controlled trial in an NHS hospital. Patients will be over 45 years old, undergoing general or neuraxial anaesthesia for non-cardiac surgery lasting 120 minutes or more. Patients will be randomly assigned to a palpation or ultrasound-guided technique for arterial cannulation. Patients will receive numbing local anaesthetic cream to the area beforehand. A needle is used to introduce the cannula into the artery. There will be a maximum of one attempt allowed. In addition to measuring success rate, we will also compare whether the successfully sited cannula provides an adequate arterial waveform, requires resiting at any point during the surgery and any complications which arise directly related to arterial catheterisation. Patients will receive standard anaesthetic and surgical care in all other respects.

Being tested
Ultrasound guided arterial cannulation, Palpation guided arterial cannulation
Keywords
Arterial cannulation, Ultrasound
Medical subject headings
Postoperative Complications

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Ultrasound guided arterial cannulationProcedure or surgery

    Arterial cannulation will be attempted at the site of the radial artery of the non-dominant hand, using real-time ultrasound guidance

  • Palpation guided arterial cannulationProcedure or surgery

    Arterial cannulation will be attempted at the site of the radial artery of the non-dominant hand, using palpation technique (standard-of-care)

Study groups in NCT05249036
Study groupRoleWhat they receive
Ultrasound guided arterial cannulationExperimentalAnaesthetist will use real-time ultrasound guidance to guide arterial cannulation
Receives: Procedure: Ultrasound guided arterial cannulation
Palpation guided arterial cannulationActive comparatorAnaesthetist will use palpation (standard-of-care) technique to guide arterial cannulation
Receives: Procedure: Palpation guided arterial cannulation

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Success rate at first attempt to cannulate the radial artery

    Success is defined as radial artery cannulation resulting in a transduced arterial waveform. First attempt is defined as one needle puncture through the skin.

    Measured: 10 minutes

Secondary outcomes (2)
  1. Characteristics of arterial waveform

    Assessment for presence of: (1) Dicrotic notch; (2) >1 oscillation after fast flush; (3) <3 oscillations after fast flush

    Measured: Within 15 mins of catheterisation.

  2. Complications

    Recannulation required before/after surgery, infection, hematoma, thrombus.

    Measured: 24 hours

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted21 Feb 2022
  2. Study start25 Dec 2021
  3. Primary completion30 Nov 2023
  4. Study completion30 Nov 2023

Why it stopped: Primary event rate far higher than estimated for sample size calculation.

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
57 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05249036
Sponsor's protocol ID
301584
Acronym
ArCanUS
Status last verified
Aug 2024
First submitted
26 Jan 2022
Last updated
15 Aug 2024
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Lan-Pak-Kee V, Ackland GL, Egan TC, Abbott TE, Elsheikh F; Arterial Cannulation with Ultrasound Investigators. Arterial cannulation with ultrasound: clinical trial protocol for a randomised controlled trial comparing handheld ultrasound versus palpation technique for radial artery cannulation. BJA Open. 2022 Dec;4:None. doi: 10.1016/j.bjao.2022.100111.

    PubMed 36561483

Questions about this trial

What is this clinical trial studying?

A study testing Ultrasound guided arterial cannulation and Palpation guided arterial cannulation in people with Perioperative/Postoperative Complications, run by Queen Mary University of London at 1 site in United Kingdom.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: stopped early, as of the sponsor's last update on 15 Aug 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United Kingdom. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study was stopped early (reason given: Primary event rate far higher than estimated for sample size calculation.). Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Success rate at first attempt to cannulate the radial artery (time frame: 10 minutes). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05249036, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 15 Aug 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in